Phase 2 Study of Oral MLN9708 in Adult Patients With Relapsed and/or Refractory Follicular Lymphoma
Read time: 1 mins
Last updated:28th Aug 2013
This is an open-label, multicenter, phase 2 study to evaluate the efficacy and safety of oral MLN9708 in adult patients with follicular lymphoma (FL) that is relapsed and/or refractory to prior treatment.
|Study start date||2013-08-28|